93 related articles for article (PubMed ID: 20218964)
1. A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysis.
Gupta SP; Samanta S; Patil VM
Med Chem; 2010 Mar; 6(2):87-90. PubMed ID: 20218964
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
Patil VM; Gupta SP; Samanta S; Masand N
Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
[TBL] [Abstract][Full Text] [Related]
4. A quantitative structure-activity relationship study on a few series of anti-hepatitis C virus agents.
Varshney J; Sharma A; Gupta SP
Med Chem; 2012 May; 8(3):491-504. PubMed ID: 22530896
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach.
Desai SP; Mohite SK; Alobid S; Saralaya MG; Patil AS; Das K; Almadani ME; Arif Hussain S; Hussain Alamer B; Abdulrahman Jibreel E; Ibrahim Almoteer A; Mohammed Basheeruddin Asdaq S
Saudi Pharm J; 2023 Dec; 31(12):101836. PubMed ID: 38028224
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies on PU3 analogues by comparative molecular field analysis.
Liu HC; Lyu PC; Leong MK; Tsai KC; Hsiue GH
Bioorg Med Chem Lett; 2004 Feb; 14(3):731-4. PubMed ID: 14741278
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship (QSAR) study of a series of benzimidazole derivatives as inhibitors of Saccharomyces cerevisiae.
Podunavac-Kuzmanović SO; Cvetković DD; Jevrić LR; Uzelac NJ
Acta Chim Slov; 2013; 60(1):26-33. PubMed ID: 23841329
[TBL] [Abstract][Full Text] [Related]
9. Development of QSAR for antimicrobial activity of substituted benzimidazoles.
Vashist N; Sambi SS; Kumar P; Narasimhan B
Drug Res (Stuttg); 2015 May; 65(5):225-30. PubMed ID: 25607748
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling, and biological evaluation of novel benzimidazole derivatives as inhibitors of hepatitis C virus RNA replication.
El Diwani HI; Abdel-Mohsen HT; Salama I; Ragab FA; Ramla MM; Galal SA; Abdalla MM; Abdel-Wahab A; El Demellawy MA
Chem Pharm Bull (Tokyo); 2014; 62(9):856-66. PubMed ID: 25177014
[TBL] [Abstract][Full Text] [Related]
11. Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site.
Ding K; Wang A; Boerneke MA; Dibrov SM; Hermann T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3113-7. PubMed ID: 24856063
[TBL] [Abstract][Full Text] [Related]
12. QSAR and docking studies of HCV NS3 serine protease inhibitors.
da Cunha EF; Matos KS; Ramalho TC
Med Chem; 2013 Sep; 9(6):774-805. PubMed ID: 23140577
[TBL] [Abstract][Full Text] [Related]
13. A QSAR study on a series of thiourea derivatives acting as anti-hepatitis C virus agents.
Sharma A; Gupta SP; Siddiqui AA
Indian J Biochem Biophys; 2013 Aug; 50(4):278-83. PubMed ID: 24772946
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
15. QSAR analysis of 2-amino or 2-methyl-1-substituted benzimidazoles against Pseudomonas aeruginosa.
Podunavac-Kuzmanović SO; Cvetković DD; Barna DJ
Int J Mol Sci; 2009 Apr; 10(4):1670-1682. PubMed ID: 19468332
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents.
Hwu JR; Singha R; Hong SC; Chang YH; Das AR; Vliegen I; De Clercq E; Neyts J
Antiviral Res; 2008 Feb; 77(2):157-62. PubMed ID: 17977606
[TBL] [Abstract][Full Text] [Related]
17. Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method.
Xiao Z; Xiao YD; Feng J; Golbraikh A; Tropsha A; Lee KH
J Med Chem; 2002 May; 45(11):2294-309. PubMed ID: 12014968
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus.
Youssif BG; Mohamed YA; Salim MT; Inagaki F; Mukai C; Abdu-Allah HH
Acta Pharm; 2016 Jun; 66(2):219-31. PubMed ID: 27279065
[TBL] [Abstract][Full Text] [Related]
20. Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus.
Tsay SC; Hwu JR; Singha R; Huang WC; Chang YH; Hsu MH; Shieh FK; Lin CC; Hwang KC; Horng JC; De Clercq E; Vliegen I; Neyts J
Eur J Med Chem; 2013 May; 63():290-8. PubMed ID: 23501114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
